HALO ์ต์ ๋ถ๊ธฐ ์์ต
๋ฐํ ๋ ์ง8/6/2026
EPS ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)1.96
์์ต ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)481.00M
Halozyme Therapeutics Inc ์ค์ ๋ฐํ ๋ ์ง ๋ฐ ๋ณด๊ณ ์
์ด ํ์ด์ง๋ ์ต์ Halozyme Therapeutics Inc ์์ต ๋ณด๊ณ ์, ๋ค๊ฐ์ค๋ Halozyme Therapeutics Inc ์ค์ ๋ฐํ ๋ ์ง, ๊ณผ๊ฑฐ ๋ฐ์ดํฐ ๋ฐ Halozyme Therapeutics Inc ์ค์ ๋ฐํ ์ปจํผ๋ฐ์ค ๋ด์ค๋ฅผ ํฌํจํ ์์ธํ Halozyme Therapeutics Inc ์์ต ๋ฐ์ดํฐ๋ฅผ ์ ๊ณตํฉ๋๋ค.
HALO ํฅํ ๋ถ๊ธฐ ์ค์
๋ฐํ ๋ ์ง--
EPS ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)--
์์ต ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)--
HALO FY2025 ์์ต
์ฐ๊ฐ ์ฃผ๋น์์ด์ต ์ฑ์ฅ๋ฅ (YoY)2.64-24.48%
์ฐ๊ฐ ๋งค์ถ ์ฑ์ฅ๋ฅ (YoY)1.40B37.55%
Halozyme Therapeutics Inc(HALO) ์ค์ ๋ด์ญ
| ๋ฐํ์ผ | ๊ธฐ๊ฐ ์ข ๋ฃ | EPS/์์ | ์์ต/์์ | EPS ์ํ๋ผ์ด์ฆ % | ์์ต ์ํ๋ผ์ด์ฆ % |
|---|---|---|---|---|---|
| 8/6/2026 | 06/2026 | 1.96/1.84 | 481.00M/407.49M | 6.78% | 18.04% |
| 5/11/2026 | 03/2026 | 1.27/1.53 | 376.71M/359.05M | -16.99% | 4.92% |
| 2/17/2026 | 12/2025 | -1.20/2.20 | 451.77M/437.98M | -154.75% | 3.15% |
| 11/3/2025 | 09/2025 | 1.49/1.63 | 354.26M/339.92M | -8.20% | 4.22% |
| 8/5/2025 | 06/2025 | 1.36/1.27 | 325.72M/285.92M | 7.51% | 13.92% |
| 5/6/2025 | 03/2025 | 0.96/0.95 | 264.86M/230.18M | 1.10% | 15.07% |
| 2/18/2025 | 12/2024 | 1.08/1.16 | 298.01M/288.24M | -6.42% | 3.39% |
| 10/31/2024 | 09/2024 | 1.08/0.98 | 290.08M/251.06M | 9.99% | 15.54% |